{"id":"https://openalex.org/W1799564847","doi":"https://doi.org/10.2337/dc15-1358","title":"The Use of Glyburide Compared With Other Sulfonylureas and the Risk of Cancer in Patients With Type 2 Diabetes","display_name":"The Use of Glyburide Compared With Other Sulfonylureas and the Risk of Cancer in Patients With Type 2 Diabetes","publication_year":2015,"publication_date":"2015-09-04","ids":{"openalex":"https://openalex.org/W1799564847","doi":"https://doi.org/10.2337/dc15-1358","mag":"1799564847","pmid":"https://pubmed.ncbi.nlm.nih.gov/26341130"},"language":"en","primary_location":{"id":"doi:10.2337/dc15-1358","doi":"https://doi.org/10.2337/dc15-1358","is_oa":false,"landing_page_url":"https://doi.org/10.2337/dc15-1358","pdf_url":null,"source":{"id":"https://openalex.org/S49878492","display_name":"Diabetes Care","issn_l":"0149-5992","issn":["0149-5992","1935-5548"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-a","doyens","jufo-3","ki-jl-3","medline","norway-2","poland-200","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320274","host_organization_name":"American Diabetes Association","host_organization_lineage":["https://openalex.org/P4310320274"],"host_organization_lineage_names":["American Diabetes Association"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Diabetes Care","raw_type":"journal-article"},"volume":null,"type":"article","indexed_in":["crossref","pubmed"],"open_access":{"is_oa":false,"oa_status":"closed","oa_url":null,"any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5058374861","display_name":"Marco Tuccori","orcid":"https://orcid.org/0000-0002-7979-8486","observed_orcids":["https://orcid.org/0000-0002-7979-8486"]},"institutions":[{"id":"https://openalex.org/I2801824472","display_name":"Jewish General Hospital","ror":"https://ror.org/056jjra10","country_code":"CA","type":"healthcare","lineage":["https://openalex.org/I2801824472","https://openalex.org/I2801902503","https://openalex.org/I4210139015","https://openalex.org/I4405256057","https://openalex.org/I4405279980"]},{"id":"https://openalex.org/I4405267356","display_name":"Lady Davis Institute for Medical Research","ror":"https://ror.org/02c1np254","country_code":"CA","type":"education","lineage":["https://openalex.org/I2801824472","https://openalex.org/I2801902503","https://openalex.org/I4210139015","https://openalex.org/I4405256057","https://openalex.org/I4405267356","https://openalex.org/I4405279980"]}],"countries":["CA"],"is_corresponding":false,"raw_author_name":"Marco Tuccori","raw_affiliation_strings":["Centre for Clinical Epidemiology, Lady Davis Institute, Jewish General Hospital, Montreal, Canada"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Centre for Clinical Epidemiology, Lady Davis Institute, Jewish General Hospital, Montreal, Canada","institution_ids":["https://openalex.org/I2801824472","https://openalex.org/I4405267356"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5026262000","display_name":"Jennifer W. Wu","orcid":"https://orcid.org/0000-0003-2841-7732","observed_orcids":["https://orcid.org/0000-0003-2841-7732"]},"institutions":[{"id":"https://openalex.org/I2801824472","display_name":"Jewish General Hospital","ror":"https://ror.org/056jjra10","country_code":"CA","type":"healthcare","lineage":["https://openalex.org/I2801824472","https://openalex.org/I2801902503","https://openalex.org/I4210139015","https://openalex.org/I4405256057","https://openalex.org/I4405279980"]},{"id":"https://openalex.org/I4405267356","display_name":"Lady Davis Institute for Medical Research","ror":"https://ror.org/02c1np254","country_code":"CA","type":"education","lineage":["https://openalex.org/I2801824472","https://openalex.org/I2801902503","https://openalex.org/I4210139015","https://openalex.org/I4405256057","https://openalex.org/I4405267356","https://openalex.org/I4405279980"]},{"id":"https://openalex.org/I5023651","display_name":"McGill University","ror":"https://ror.org/01pxwe438","country_code":"CA","type":"education","lineage":["https://openalex.org/I5023651"]}],"countries":["CA"],"is_corresponding":false,"raw_author_name":"Jennifer W. Wu","raw_affiliation_strings":["Centre for Clinical Epidemiology, Lady Davis Institute, Jewish General Hospital, Montreal, Canada","Department of Epidemiology, Biostatistics, and Occupational Health, McGill University, Montreal, Canada"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Centre for Clinical Epidemiology, Lady Davis Institute, Jewish General Hospital, Montreal, Canada","institution_ids":["https://openalex.org/I2801824472","https://openalex.org/I4405267356"]},{"raw_affiliation_string":"Department of Epidemiology, Biostatistics, and Occupational Health, McGill University, Montreal, Canada","institution_ids":["https://openalex.org/I5023651"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5111751549","display_name":"Hui Yin","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I2801824472","display_name":"Jewish General Hospital","ror":"https://ror.org/056jjra10","country_code":"CA","type":"healthcare","lineage":["https://openalex.org/I2801824472","https://openalex.org/I2801902503","https://openalex.org/I4210139015","https://openalex.org/I4405256057","https://openalex.org/I4405279980"]},{"id":"https://openalex.org/I4405267356","display_name":"Lady Davis Institute for Medical Research","ror":"https://ror.org/02c1np254","country_code":"CA","type":"education","lineage":["https://openalex.org/I2801824472","https://openalex.org/I2801902503","https://openalex.org/I4210139015","https://openalex.org/I4405256057","https://openalex.org/I4405267356","https://openalex.org/I4405279980"]}],"countries":["CA"],"is_corresponding":false,"raw_author_name":"Hui Yin","raw_affiliation_strings":["Centre for Clinical Epidemiology, Lady Davis Institute, Jewish General Hospital, Montreal, Canada"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Centre for Clinical Epidemiology, Lady Davis Institute, Jewish General Hospital, Montreal, Canada","institution_ids":["https://openalex.org/I2801824472","https://openalex.org/I4405267356"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5044608847","display_name":"Agnieszka Majdan","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I2801824472","display_name":"Jewish General Hospital","ror":"https://ror.org/056jjra10","country_code":"CA","type":"healthcare","lineage":["https://openalex.org/I2801824472","https://openalex.org/I2801902503","https://openalex.org/I4210139015","https://openalex.org/I4405256057","https://openalex.org/I4405279980"]}],"countries":["CA"],"is_corresponding":false,"raw_author_name":"Agnieszka Majdan","raw_affiliation_strings":["Division of Endocrinology, Jewish General Hospital, Montreal, Canada"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Division of Endocrinology, Jewish General Hospital, Montreal, Canada","institution_ids":["https://openalex.org/I2801824472"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5028735116","display_name":"Laurent Azoulay","orcid":"https://orcid.org/0000-0001-5162-3556","observed_orcids":["https://orcid.org/0000-0001-5162-3556"]},"institutions":[{"id":"https://openalex.org/I2801824472","display_name":"Jewish General Hospital","ror":"https://ror.org/056jjra10","country_code":"CA","type":"healthcare","lineage":["https://openalex.org/I2801824472","https://openalex.org/I2801902503","https://openalex.org/I4210139015","https://openalex.org/I4405256057","https://openalex.org/I4405279980"]},{"id":"https://openalex.org/I4405267356","display_name":"Lady Davis Institute for Medical Research","ror":"https://ror.org/02c1np254","country_code":"CA","type":"education","lineage":["https://openalex.org/I2801824472","https://openalex.org/I2801902503","https://openalex.org/I4210139015","https://openalex.org/I4405256057","https://openalex.org/I4405267356","https://openalex.org/I4405279980"]},{"id":"https://openalex.org/I5023651","display_name":"McGill University","ror":"https://ror.org/01pxwe438","country_code":"CA","type":"education","lineage":["https://openalex.org/I5023651"]}],"countries":["CA"],"is_corresponding":true,"raw_author_name":"Laurent Azoulay","raw_affiliation_strings":["Centre for Clinical Epidemiology, Lady Davis Institute, Jewish General Hospital, Montreal, Canada","Department of Oncology, McGill University, Montreal, Canada"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Centre for Clinical Epidemiology, Lady Davis Institute, Jewish General Hospital, Montreal, Canada","institution_ids":["https://openalex.org/I2801824472","https://openalex.org/I4405267356"]},{"raw_affiliation_string":"Department of Oncology, McGill University, Montreal, Canada","institution_ids":["https://openalex.org/I5023651"]}]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":3,"corresponding_author_ids":["https://openalex.org/A5028735116"],"corresponding_institution_ids":["https://openalex.org/I2801824472","https://openalex.org/I4405267356","https://openalex.org/I5023651"],"apc_list":null,"apc_paid":null,"fwci":1.5904,"has_fulltext":false,"cited_by_count":38,"citation_normalized_percentile":{"value":0.8230181,"is_in_top_1_percent":false,"is_in_top_10_percent":false},"cited_by_percentile_year":{"min":89,"max":99},"biblio":{"volume":"38","issue":"11","first_page":"2083","last_page":"2089"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T11339","display_name":"Metabolism, Diabetes, and Cancer","score":0.5946999788284302,"subfield":{"id":"https://openalex.org/subfields/1312","display_name":"Molecular Biology"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},"topics":[{"id":"https://openalex.org/T11339","display_name":"Metabolism, Diabetes, and Cancer","score":0.5946999788284302,"subfield":{"id":"https://openalex.org/subfields/1312","display_name":"Molecular Biology"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T10401","display_name":"Diabetes Treatment and Management","score":0.3801000118255615,"subfield":{"id":"https://openalex.org/subfields/2712","display_name":"Endocrinology, Diabetes and Metabolism"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10231","display_name":"Pancreatic and Hepatic Oncology Research","score":0.0024999999441206455,"subfield":{"id":"https://openalex.org/subfields/2730","display_name":"Oncology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/glibenclamide","display_name":"glibenclamide","score":1.0},{"id":"https://openalex.org/keywords/sulfonylureas","display_name":"sulfonylureas","score":0.9179999828338623},{"id":"https://openalex.org/keywords/second-generation-sulfonylureas","display_name":"second-generation sulfonylureas","score":0.9279999732971191},{"id":"https://openalex.org/keywords/type-2-diabetes","display_name":"type 2 diabetes","score":0.8989999890327454},{"id":"https://openalex.org/keywords/cancer-risk","display_name":"cancer risk","score":0.9959999918937683},{"id":"https://openalex.org/keywords/drug-safety","display_name":"drug safety","score":0.5080000162124634},{"id":"https://openalex.org/keywords/duration-of-drug-use","display_name":"duration of drug use","score":0.7229999899864197},{"id":"https://openalex.org/keywords/cumulative-dose","display_name":"cumulative dose","score":0.8399999737739563},{"id":"https://openalex.org/keywords/defined-daily-doses","display_name":"defined daily doses","score":0.7459999918937683}],"concepts":[{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.9472934603691101},{"id":"https://openalex.org/C88879693","wikidata":"https://www.wikidata.org/wiki/Q217690","display_name":"Cumulative incidence","level":3,"score":0.7460009455680847},{"id":"https://openalex.org/C207103383","wikidata":"https://www.wikidata.org/wiki/Q3930246","display_name":"Hazard ratio","level":3,"score":0.6896865963935852},{"id":"https://openalex.org/C50382708","wikidata":"https://www.wikidata.org/wiki/Q223218","display_name":"Proportional hazards model","level":2,"score":0.656451404094696},{"id":"https://openalex.org/C151032500","wikidata":"https://www.wikidata.org/wiki/Q5194182","display_name":"Cumulative dose","level":2,"score":0.632889449596405},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.6165366172790527},{"id":"https://openalex.org/C555293320","wikidata":"https://www.wikidata.org/wiki/Q12206","display_name":"Diabetes mellitus","level":2,"score":0.5363876223564148},{"id":"https://openalex.org/C121608353","wikidata":"https://www.wikidata.org/wiki/Q12078","display_name":"Cancer","level":2,"score":0.48252007365226746},{"id":"https://openalex.org/C2908647359","wikidata":"https://www.wikidata.org/wiki/Q2625603","display_name":"Population","level":2,"score":0.479636013507843},{"id":"https://openalex.org/C72563966","wikidata":"https://www.wikidata.org/wiki/Q1303415","display_name":"Cohort","level":2,"score":0.47944989800453186},{"id":"https://openalex.org/C2777180221","wikidata":"https://www.wikidata.org/wiki/Q3025883","display_name":"Type 2 diabetes","level":3,"score":0.4762204587459564},{"id":"https://openalex.org/C201903717","wikidata":"https://www.wikidata.org/wiki/Q1778788","display_name":"Cohort study","level":2,"score":0.45917844772338867},{"id":"https://openalex.org/C61511704","wikidata":"https://www.wikidata.org/wiki/Q1671857","display_name":"Incidence (geometry)","level":2,"score":0.41772791743278503},{"id":"https://openalex.org/C44249647","wikidata":"https://www.wikidata.org/wiki/Q208498","display_name":"Confidence interval","level":2,"score":0.22716030478477478},{"id":"https://openalex.org/C134018914","wikidata":"https://www.wikidata.org/wiki/Q162606","display_name":"Endocrinology","level":1,"score":0.19737282395362854},{"id":"https://openalex.org/C99454951","wikidata":"https://www.wikidata.org/wiki/Q932068","display_name":"Environmental health","level":1,"score":0.06380107998847961},{"id":"https://openalex.org/C121332964","wikidata":"https://www.wikidata.org/wiki/Q413","display_name":"Physics","level":0,"score":0.0},{"id":"https://openalex.org/C120665830","wikidata":"https://www.wikidata.org/wiki/Q14620","display_name":"Optics","level":1,"score":0.0}],"mesh":[{"descriptor_ui":"D000368","descriptor_name":"Aged","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D003924","descriptor_name":"Diabetes Mellitus, Type 2","qualifier_ui":"Q000188","qualifier_name":"drug therapy","is_major_topic":true},{"descriptor_ui":"D005260","descriptor_name":"Female","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D005905","descriptor_name":"Glyburide","qualifier_ui":"Q000009","qualifier_name":"adverse effects","is_major_topic":true},{"descriptor_ui":"D005905","descriptor_name":"Glyburide","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":false},{"descriptor_ui":"D006801","descriptor_name":"Humans","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D007004","descriptor_name":"Hypoglycemic Agents","qualifier_ui":"Q000009","qualifier_name":"adverse effects","is_major_topic":true},{"descriptor_ui":"D007004","descriptor_name":"Hypoglycemic Agents","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":false},{"descriptor_ui":"D008297","descriptor_name":"Male","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D008875","descriptor_name":"Middle Aged","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D009369","descriptor_name":"Neoplasms","qualifier_ui":"Q000139","qualifier_name":"chemically induced","is_major_topic":true},{"descriptor_ui":"D009369","descriptor_name":"Neoplasms","qualifier_ui":"Q000209","qualifier_name":"etiology","is_major_topic":false},{"descriptor_ui":"D012189","descriptor_name":"Retrospective Studies","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D012307","descriptor_name":"Risk Factors","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D013453","descriptor_name":"Sulfonylurea Compounds","qualifier_ui":"Q000009","qualifier_name":"adverse effects","is_major_topic":true},{"descriptor_ui":"D013453","descriptor_name":"Sulfonylurea Compounds","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":false},{"descriptor_ui":"D015331","descriptor_name":"Cohort Studies","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false}],"locations_count":2,"locations":[{"id":"doi:10.2337/dc15-1358","doi":"https://doi.org/10.2337/dc15-1358","is_oa":false,"landing_page_url":"https://doi.org/10.2337/dc15-1358","pdf_url":null,"source":{"id":"https://openalex.org/S49878492","display_name":"Diabetes Care","issn_l":"0149-5992","issn":["0149-5992","1935-5548"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-a","doyens","jufo-3","ki-jl-3","medline","norway-2","poland-200","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320274","host_organization_name":"American Diabetes Association","host_organization_lineage":["https://openalex.org/P4310320274"],"host_organization_lineage_names":["American Diabetes Association"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Diabetes Care","raw_type":"journal-article"},{"id":"pmid:26341130","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/26341130","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Diabetes care","raw_type":"Comparative Study"}],"best_oa_location":null,"sustainable_development_goals":[{"id":"https://metadata.un.org/sdg/3","display_name":"Good health and well-being","score":1.0}],"study_designs":[{"id":"https://openalex.org/study-designs/observational-study","display_name":"Observational Study"}],"awards":[],"funders":[{"id":"https://openalex.org/F4320334506","display_name":"Canadian Institutes of Health Research","ror":"https://ror.org/01gavpb45"}],"has_content":{"pdf":false,"grobid_xml":false},"content_urls":null,"referenced_works_count":39,"referenced_works":["https://openalex.org/W24787878","https://openalex.org/W1527814995","https://openalex.org/W1964274975","https://openalex.org/W1965111919","https://openalex.org/W1972938596","https://openalex.org/W1984724550","https://openalex.org/W1989022681","https://openalex.org/W2005580360","https://openalex.org/W2013047715","https://openalex.org/W2014695552","https://openalex.org/W2020503356","https://openalex.org/W2024535852","https://openalex.org/W2037316673","https://openalex.org/W2038981426","https://openalex.org/W2040492681","https://openalex.org/W2057015212","https://openalex.org/W2061145056","https://openalex.org/W2074003955","https://openalex.org/W2079396916","https://openalex.org/W2085331940","https://openalex.org/W2102994534","https://openalex.org/W2109000468","https://openalex.org/W2109392254","https://openalex.org/W2111714917","https://openalex.org/W2115408067","https://openalex.org/W2118679172","https://openalex.org/W2121877929","https://openalex.org/W2123443745","https://openalex.org/W2127753192","https://openalex.org/W2139685699","https://openalex.org/W2141763052","https://openalex.org/W2142292261","https://openalex.org/W2156370651","https://openalex.org/W2157836715","https://openalex.org/W2164595809","https://openalex.org/W2169214947","https://openalex.org/W2170398372","https://openalex.org/W2171100237","https://openalex.org/W2171646682"],"related_works":["https://openalex.org/W2139685699","https://openalex.org/W4283721296","https://openalex.org/W2061145056","https://openalex.org/W2417046068","https://openalex.org/W3024209008","https://openalex.org/W2701624882","https://openalex.org/W4411291442","https://openalex.org/W2136644409","https://openalex.org/W2911084790","https://openalex.org/W6944144409"],"abstract_inverted_index":{"OBJECTIVE:":[0],"To":[1],"determine":[2,103],"whether":[3,104],"the":[4,18,87,93,105,147,153],"use":[5,19,88,94,112,148,154],"of":[6,14,20,82,89,95,111,126,135,149,155,164,193,223,231],"glyburide":[7,52,90,156,224],"is":[8],"associated":[9,85,158,188,226],"with":[10,17,26,86,92,108,146,159,181,189,227],"an":[11,190,228],"increased":[12,162,191,229],"risk":[13,163,192,230],"cancer":[15,84,136,166,195],"compared":[16,91,145],"other":[21,54,150],"second-generation":[22,55,96,151],"sulfonylureas":[23,56],"among":[24,47],"patients":[25,49,129],"type":[27],"2":[28],"diabetes.":[29],"RESEARCH":[30],"DESIGN":[31],"AND":[32],"METHODS:":[33],"The":[34],"U.K.":[35],"Clinical":[36],"Practice":[37],"Research":[38],"Datalink":[39],"was":[40,71,157],"used":[41,72],"to":[42,73,102],"conduct":[43],"a":[44,132,160],"cohort":[45,214],"study":[46],"52,600":[48],"newly":[50],"prescribed":[51],"or":[53],"between":[57],"1":[58],"January":[59],"1988":[60],"and":[61,79,113,176,185,219],"31":[62],"July":[63],"2013.":[64],"A":[65],"time-dependent":[66],"Cox":[67],"proportional":[68],"hazards":[69],"model":[70],"estimate":[74],"adjusted":[75],"hazard":[76],"ratios":[77],"(HRs)":[78],"95%":[80],"CIs":[81],"any":[83,165,194],"sulfonylureas.":[97],"Secondary":[98],"analyses":[99],"were":[100,130,179,225],"conducted":[101],"association":[106],"varied":[107],"cumulative":[109,114,183,186,217,221],"duration":[110],"dose":[115,120],"(expressed":[116],"as":[117],"defined":[118],"daily":[119],"[DDD]).":[121],"RESULTS:":[122],"During":[123],"280,288":[124],"person-years":[125],"follow-up,":[127],"4,105":[128],"given":[131],"new":[133],"diagnosis":[134],"(incidence":[137],"rate":[138],"14.6":[139],"per":[140],"1,000":[141],"person-years).":[142],"Overall,":[143],"when":[144],"sulfonylureas,":[152],"nonsignificant":[161],"(HR":[167],"1.09":[168],"[95%":[169,200,207],"CI":[170,208],"0.98-1.22]).":[171],"In":[172,211],"secondary":[173],"analyses,":[174],"duration-":[175],"dose-response":[177],"relationships":[178],"observed,":[180],"longer":[182,216],"durations":[184,218],"doses":[187,222],"(>36":[196],"months:":[197],"HR":[198,205],"1.21":[199],"CI:":[201],"1.03-1.42];":[202],">1,096":[203],"DDDs:":[204],"1.27":[206],"1.06-1.51]).":[209],"CONCLUSIONS:":[210],"this":[212],"population-based":[213],"study,":[215],"higher":[220],"cancer.":[232]},"counts_by_year":[{"year":2026,"cited_by_count":5},{"year":2025,"cited_by_count":2},{"year":2024,"cited_by_count":1},{"year":2023,"cited_by_count":4},{"year":2021,"cited_by_count":4},{"year":2020,"cited_by_count":5},{"year":2019,"cited_by_count":6},{"year":2018,"cited_by_count":4},{"year":2017,"cited_by_count":5},{"year":2016,"cited_by_count":2}],"updated_date":"2026-10-31T12:09:11.096373","created_date":"2016-06-24T00:00:00"}